Home Gala Therapeutics

Gala Therapeutics

12-Month Data Published in the American Journal of Respiratory and Critical Care Medicine, Demonstrate the Safety and Feasibility of RheOx ™ Bronchial Rheoplasty System for Chronic Bronchitis

The study assessed safety, changes in airway histopathology and quality of life. Performed using a minimally invasive bronchoscopic procedure called Bronchial Rheoplasty, the RheOx System delivers non-thermal pulsed energy to the airways in the lungs to reduce mucus-producing cells, improving the symptoms of cough and mucus.